10x Genomics wins jury verdict against Parse in Delaware patent case, awarded over $4.8 million

Reuters2026/08/28 18:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

10x Genomics won a U.S. jury verdict finding Parse Biosciences willfully infringed three Scale Biosciences patents licensed from Roche Sequencing Solutions.
Jury rejected Parse’s invalidity challenge, upholding the patents as valid and enforceable in the District of Delaware case.
Damages set at over $4.8 million on a 14% royalty for Evercode Whole Transcriptome sales from February 2021 through June 30, 2026.
Post-trial requests to seek enhanced damages, attorneys’ fees, and a permanent U.S. injunction against further infringement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608281438PR_NEWS_USPR_____LA36282) on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

10x Genomics wins jury verdict against Parse in Delaware patent case, awarded over $4.8 million

You may also like

Crypto prices